Home
Storia in 1 fonti
China-Developed ALS Therapy Shows Early Trial Promise
In a six-patient trial, a new gene-silencing drug reduced disease-related biomarkers, with no serious adverse events reported.
Raccontata da
sixthtone.com
In a six-patient trial, a new gene-silencing drug reduced disease-related biomarkers, with no serious adverse events reported.
